These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38340380)

  • 21. Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.
    Hulsebosch SE; Pires J; Bannasch MJ; Lancaster T; Delpero A; Ragupathy R; Murikipudi S; Zion T; Gilor C
    J Vet Intern Med; 2022 Jul; 36(4):1211-1219. PubMed ID: 35621084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice.
    Muñoz OM; Gómez AM; Maira GJ; Fabián Mauricio LV; Ruiz-Morales ÁJ
    Diabetes Metab Syndr; 2018 Jul; 12(4):555-561. PubMed ID: 29631779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic variability indices can be used to diagnose islet transplantation success in type 1 diabetic patients.
    Jalbert M; Zheng F; Wojtusciszyn A; Forbes F; Bonnet S; Skaare K; Benhamou PY; Lablanche S;
    Acta Diabetol; 2020 Mar; 57(3):335-345. PubMed ID: 31602530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycemic Variability in Type 1 Diabetes Mellitus Saudis Using Ambulatory Glucose Profile.
    Alzahrani B; Alzahrani S; Almalki MH; Elabd SS; Khan SA; Buhary B; Aljuhani N; Jammah AA
    Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211013789. PubMed ID: 34017209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
    Šoupal J; Škrha J; Fajmon M; Horová E; Mráz M; Škrha J; Prázný M
    Diabetes Technol Ther; 2014 Apr; 16(4):198-203. PubMed ID: 24401008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic variability leads to higher levels of auto-oxidized oxysterol species in patients with type 1 diabetes mellitus.
    Ünlütürk U; Bahçecioğlu AB; Samadi A; Lay I; Bayraktar M; Dağdelen S
    J Endocrinol Invest; 2023 Dec; 46(12):2547-2554. PubMed ID: 37188911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of day-to-day variability of serial blood glucose concentration curves in diabetic dogs.
    Fleeman LM; Rand JS
    J Am Vet Med Assoc; 2003 Feb; 222(3):317-21. PubMed ID: 12564593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
    Li LQ; Yao MY; Ma JX; Xue P; Li YK
    Endocr J; 2019 Oct; 66(10):871-880. PubMed ID: 31243192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
    Kasthuri S; Poongothai S; Anjana RM; Selvakumar J; Muthukumar S; Kayalvizhi S; Tariq S; Honey E; Gupta PK; Venkatesan U; Mohan V
    Diabetes Technol Ther; 2021 Mar; 23(3):213-220. PubMed ID: 32916063
    [No Abstract]   [Full Text] [Related]  

  • 30. Short-term Glycemic Variability and Its Association With Macrovascular and Microvascular Complications in Patients With Diabetes.
    Psoma O; Makris M; Tselepis A; Tsimihodimos V
    J Diabetes Sci Technol; 2024 Jul; 18(4):956-967. PubMed ID: 36576014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.
    Oe Y; Nomoto H; Nakamura A; Kuwabara S; Takahashi Y; Yasui A; Izumihara R; Miya A; Kameda H; Cho KY; Atsumi T; Miyoshi H
    J Diabetes Res; 2022; 2022():5603864. PubMed ID: 35097130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.
    Marling CR; Shubrook JH; Vernier SJ; Wiley MT; Schwartz FL
    J Diabetes Sci Technol; 2011 Jul; 5(4):871-8. PubMed ID: 21880228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Test-retest reliability of a continuous glucose monitoring system in individuals with type 2 diabetes.
    Terada T; Loehr S; Guigard E; McCargar LJ; Bell GJ; Senior P; Boulé NG
    Diabetes Technol Ther; 2014 Aug; 16(8):491-8. PubMed ID: 24815725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study.
    Yao MY; Li LQ; Ma JX; Xue P; Li YK
    Braz J Med Biol Res; 2020; 53(1):e8652. PubMed ID: 31859911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial.
    Iuchi H; Sakamoto M; Matsutani D; Suzuki H; Horiuchi R; Utsunomiya K
    Diabetes Technol Ther; 2017 Aug; 19(8):457-462. PubMed ID: 28605286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis.
    Yusof Khan AHK; Zakaria NF; Zainal Abidin MA; Kamaruddin NA
    Medicine (Baltimore); 2021 Jul; 100(30):e26729. PubMed ID: 34397709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes.
    Henao-Carrillo DC; Muñoz OM; Gómez AM; Rondón M; Colón C; Chica L; Rubio C; León-Vargas F; Calvachi MA; Perea AM
    J Clin Transl Endocrinol; 2018 Jun; 12():8-12. PubMed ID: 29892561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between a flash glucose monitoring system and a portable blood glucose meter for monitoring dogs with diabetes mellitus.
    Del Baldo F; Canton C; Testa S; Swales H; Drudi I; Golinelli S; Fracassi F
    J Vet Intern Med; 2020 Nov; 34(6):2296-2305. PubMed ID: 33124730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen.
    Lin YH; Lin CH; Huang YY; Chen HY; Tai AS; Fu SC; Hsieh SH; Sun JH; Chen ST; Lin SH
    Eur J Med Res; 2022 Dec; 27(1):273. PubMed ID: 36463197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.